Ted Murphy - 23 May 2025 Form 4 Insider Report for Co-Diagnostics, Inc. (CODX)

Reporting relationship: Director
Issuer ticker: CODX
Reported as of: 23 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 May 2025, 16:09:01 UTC
Prior SEC filing: 25 Nov 2024
Next SEC filing: 15 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Edward L. Murphy

Key filing fact

Ted Murphy filed Form 4 for Co-Diagnostics, Inc. (CODX) on 27 May 2025.

Key facts

This page summarizes Ted Murphy's Form 4 filing for Co-Diagnostics, Inc. (CODX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 27 May 2025, 16:09.

Change

Previous filing in this sequence was filed on 25 Nov 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001685432 Primary reporting owner

MURPHY TED

Relationship: Director
Address: 2401 S. FOOTHILL DRIVE SUITE D, SALT LAKE CITY
Signature: /s/ Edward L. Murphy
Signature date: 27 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CODX transaction

Common Stock

Award

Transaction value: $0
Shares: +48,334
Change %: +27%
Price: $0.000000
Shares after: 224,167
Date: 23 May 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CODX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -48,334
Change %: -32%
Price: $0.000000
Shares after: 103,333
Date: 23 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 151,667
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Included in 70,000 restricted stock units awarded to the Reporting Person on July 7, 2022, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2022. Included in 40,000 restricted stock units awarded to the Reporting Person on January 17, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on May 23, 2023. Included in 70,000 restricted stock units awarded to the Reporting Person on June 12, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2023. Included in 110,000 restricted stock units awarded to the Reporting Person on April 26, 2024, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2024.